Detect Neurotoxic Risk Early. Support CNS Drug Development.
Our neurotoxicity services are designed to identify functional effects on neurons and neuronal networks, supporting safer and more efficient CNS and non-CNS drug development.
Our neurotoxicity services are supported by validated electrophysiology platforms widely used in neuroscience research.
SyncroPatch 384 — Nanion Technologies
High-throughput automated patch clamp for neuronal ion channels.
The SyncroPatch 384 provides parallel whole-cell recordings for the functional screening of neuronal ion channel targets, particularly using recombinant over-expression cell lines of relevant channels (Nav, Cav, Kv, and others). It supports rapid concentration-response profiling for hit-to-lead prioritisation.
Best suited for: High-throughput ion channel screening, over-expression cell lines, IC50 determination
NANION TECHNOLOGIES HIGH THROUGHPUT
Patchliner — Nanion Technologies
Automated patch clamp for neuronal ion channel studies.
The Patchliner enables functional assessment of ion channel activity in neuronal systems. It provides automated whole-cell recordings from neurons and neuronal cell lines, allowing for the evaluation of compound effects on neuronal excitability and ion channel function.
Best suited for: Neuronal ion channel screening, medium-throughput neurotoxicity assessment, functional profiling
NANION TECHNOLOGIES MEDIUM THROUGHPUT
Manual Patch Clamp
Detailed characterization of neuronal excitability and firing properties.
Conventional whole-cell electrophysiology systems provide high-resolution recordings of neuronal activity. This gold-standard approach allows for detailed analysis of action potential properties, firing patterns, and synaptic responses in individual neurons.
Best suited for: Detailed neuronal characterization, action potential analysis, synaptic transmission studies
GOLD STANDARD HIGH RESOLUTION
MEA Systems — Multi Channel Systems (MCS)
Long-term, non-invasive recordings of neuronal network activity.
Multi-Electrode Array (MEA) technology enables simultaneous recording from multiple electrodes in neuronal networks over extended periods. This approach captures emergent network properties, including synchronization, burst dynamics, and functional connectivity that cannot be observed at the single-cell level.
Best suited for: Network-level neurotoxicity assessment, seizure liability detection, chronic exposure studies
MCS NETWORK PHYSIOLOGY
Voltage Sensitive Dyes (VSD)
Optical readout of neuronal membrane potential.
Voltage-sensitive dye imaging records changes in membrane potential across intact neuronal populations, providing a complement to MEA field-potential recordings with single-cell spatial resolution and the ability to detect sub-threshold voltage events.
Best suited for: Population-level excitability, sub-threshold events, spatial activity mapping
OPTICAL POPULATION-LEVEL
High-Speed sCMOS Imaging (Kinetix)
High-speed optical imaging for neuronal function.
The Kinetix sCMOS camera enables high-frame-rate calcium and voltage imaging of neuronal cultures and 3D spheroids, capturing network activity, calcium homeostasis, and compound-induced changes with population-level spatial context.
Best suited for: Calcium imaging, 3D spheroid activity, network burst analysis
TELEDYNE PHOTOMETRICS HIGH SPEED
Definition of neurotoxicity endpoints aligned with project goals.
Selection of neuronal model and electrophysiological approach.
Stable recordings with rigorous acceptance criteria.
Functional interpretation at single-cell and network levels.
Common questions about ChanPharm's neurotoxicity screening, iPSC neuron assays, and MEA network-activity analysis.
Which neuronal models do you use for neurotoxicity screening?
Human iPSC-derived neurons (sensory, cortical, motor and others), primary dorsal root ganglion (DRG) and other neuronal cultures, and recombinant cell lines expressing neuronal ion channels — selected per study to balance throughput, physiological relevance, and translational confidence. See our stem cell studies page for the full range of cell models.
Can you detect seizurogenic liability early?
Yes. Our multi-electrode array (MEA) network-activity assays detect changes in firing rate, bursts structure, and network-level synchrony that flag seizure risk well before in vivo studies. This catches CNS-active liabilities at hit-to-lead stage, saving downstream attrition cost.
Which neuronal ion channel targets do you cover?
Nav1.1–Nav1.9 (including Nav1.7 and Nav1.8 for pain programmes), the Cav family including T-type Cav3.2, Kv1.x and Kv7.x, NMDA receptors (GluN1/GluN2B), GABA-A receptors, TRPA1, TRPV1, and custom targets on request.
How do you combine MEA with patch clamp for neurotoxicity workflows?
We use MEA for network-level screening (high throughput, integrated electrophysiology) and follow up with manual or automated patch clamp to pinpoint the underlying single-cell mechanism — voltage-gated channel block, receptor antagonism, kinetic effects. This MEA→patch funnel is much more informative than either readout alone.
Do you provide expert interpretation of complex neuronal data?
Yes. Our team has decades of academic and industrial experience in neuronal electrophysiology, led by Prof. Steffen Hering. Reports include biophysical interpretation of MEA network signatures and patch-clamp data — voltage-dependence, state-dependence, kinetics — not just summary numbers.